Identification of coexistence of BRAF V600E mutation and EZH2 gain specifically in melanoma as a promising target for combination therapy

Overview of attention for article published in Journal of Translational Medicine, December 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 1,562 followers.

RT @Covaris: Identification of coexistence of BRAF V600E mutation and EZH2 gain specifically in melanoma as a promising target for combinat…

27 Mar 2018

Reply Repost Favourite

RT @Covaris: Identification of coexistence of BRAF V600E mutation and EZH2 gain specifically in melanoma as a promising target for combinat…

26 Mar 2018

Reply Repost Favourite

RT @Covaris: Identification of coexistence of BRAF V600E mutation and EZH2 gain specifically in melanoma as a promising target for combinat…

26 Mar 2018

Reply Repost Favourite

Identification of coexistence of BRAF V600E mutation and EZH2 gain specifically in melanoma as a promising target for combination therapy with sheared DNA using the Covaris S2 Focused-ultrasonicator by Yu et al. https://t.co/XGmyD8rPr9

26 Mar 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.